Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tetanus antitoxin, human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
Administration of Tetanus immune globulin, human |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Intramuscular injection of human tetanus immunoglobulin |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Infusion of tetanus antitoxin (procedure) |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Injection of tetanus antitoxin (procedure) |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Anti-tetanus immunoglobulin injection (procedure) |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Administration of tetanus antitoxin (procedure) |
Direct substance |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
1 |
Tetanus immunoglobulin adverse reaction |
Causative agent (attribute) |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
Allergy to tetanus immunoglobulin (finding) |
Causative agent (attribute) |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
flacon d'une solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
flacon d'une solution pour perfusion de 2500 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
seringue préremplie avec solution injectable de 250 UI d'immunoglobuline antitétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
Product containing human tetanus immunoglobulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|
Antitetanus immunoglob. injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus antitoxin |
Inferred relationship |
Some |
|